Dow Rises on Covid-19 Vaccine Results
The blue-chip index climbed after promising results on a Covid-19 vaccine bolstered hopes for an economic rebound in 2021.
U.S. Business Activity Accelerates in November
Business activity picked up to a more-than-five-year high in November despite the surge in coronavirus cases and tightening restrictions, with IHS Markit's U.S. Composite Output Index hitting 57.9, up from 56.3 in October.
U.S. Economic Activity Picks Up on Postelection Lift, Vaccine Results
The U.S. economy continues to recover from the downturn caused by the pandemic, according to business surveys that show services and manufacturing activity growing, while surveys show the European economy is set for a fresh contraction in the final quarter of 2020.
Asia's Hydrogen Fuel Future May Be Coalescing
There is still a long way to go for hydrogen to justify the hype as the next big thing in transportation. But Asia may hold the key to any eventual success.
Bitcoin Trades Near Record, Finds New Audience
The cryptocurrency has attracted a broad array of investors, including the Wall Street billionaires Paul Tudor Jones and Stanley Druckenmiller as well as sports radio host Gregg Giannotti.
Vaccines Won't Save Eurozone From Double-Dip Recession
Positive clinical-trial results have cheered markets, but the economy faces a tough winter ahead before a shot becomes widely available
Derby's Take: Treasury Move on Emergency Lending Unsettles Stimulus Debate
The Treasury Department's surprise move to end emergency-lending efforts done jointly with the Federal Reserve has rattled an already uncertain outlook for what the central bank might do to help the economy.
Trump's China Blacklist Sparks Reviews at Index Compilers
FTSE Russell, JPMorgan Chase and MSCI are rethinking their stance on securities from companies that the U.S. government says help the Chinese military.
AstraZeneca-Oxford Vaccine Up to 90% Effective in Trials
The success of the vaccine being developed by the University of Oxford and AstraZeneca bodes well for the near-term availability of a third treatment for Covid-19, joining those from Moderna as well as Pfizer and BioNTech.
China Vows to Investigate Bond-Market Misconduct
A body that groups together China's central bank and other top financial regulators and that is chaired by Vice Premier Liu He issued the warning after a series of defaults by state-backed groups unsettled investors.
(END) Dow Jones Newswires